Myasthenic syndrome associated with antibiotics.
D002118:Calcium / Q000627:therapeutic use; D003091:Colistin / Q000009:adverse effects*; D004576:Electromyography; D006801:Humans; D006996:Hypocalcemia / Q000188:drug therapy; D007612:Kanamycin / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000188:drug therapy; D009388:Neostigmine / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D010264:Paraplegia / Q000150:complications; D011704:Pyelonephritis / Q000188:drug therapy; D012131:Respiratory Insufficiency; D009435:Synaptic Transmission
D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D007612:Kanamycin; D002118:Calcium; D003091:Colistin